Clarivate Plc (NYSE:CLVT) Receives Average Rating of “Hold” from Analysts

Shares of Clarivate Plc (NYSE:CLVTGet Free Report) have earned a consensus recommendation of “Hold” from the nine ratings firms that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $7.78.

Separately, The Goldman Sachs Group cut their target price on Clarivate from $8.50 to $7.50 and set a “buy” rating for the company in a research note on Thursday, May 9th.

Read Our Latest Report on Clarivate

Hedge Funds Weigh In On Clarivate

A number of institutional investors have recently added to or reduced their stakes in the company. Exor N.V. raised its holdings in Clarivate by 2.4% in the first quarter. Exor N.V. now owns 67,294,884 shares of the company’s stock worth $500,001,000 after purchasing an additional 1,566,519 shares in the last quarter. Impactive Capital LP raised its holdings in Clarivate by 0.3% in the first quarter. Impactive Capital LP now owns 37,887,185 shares of the company’s stock worth $281,502,000 after purchasing an additional 109,247 shares in the last quarter. Baupost Group LLC MA raised its holdings in Clarivate by 20.0% in the first quarter. Baupost Group LLC MA now owns 30,598,402 shares of the company’s stock worth $227,346,000 after purchasing an additional 5,098,402 shares in the last quarter. Glenview Capital Management LLC increased its holdings in shares of Clarivate by 22.2% during the fourth quarter. Glenview Capital Management LLC now owns 24,651,047 shares of the company’s stock valued at $228,269,000 after acquiring an additional 4,472,302 shares in the last quarter. Finally, Vanguard Group Inc. increased its holdings in shares of Clarivate by 2.2% during the third quarter. Vanguard Group Inc. now owns 7,986,939 shares of the company’s stock valued at $53,592,000 after acquiring an additional 171,326 shares in the last quarter. Institutional investors own 85.72% of the company’s stock.

Clarivate Stock Down 1.1 %

CLVT stock opened at $6.41 on Friday. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 1.03. The company’s 50 day moving average is $5.90 and its 200 day moving average is $7.03. The stock has a market cap of $4.28 billion, a price-to-earnings ratio of -3.86, a price-to-earnings-growth ratio of 4.55 and a beta of 1.15. Clarivate has a 1-year low of $5.19 and a 1-year high of $9.60.

Clarivate (NYSE:CLVTGet Free Report) last issued its earnings results on Wednesday, May 8th. The company reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.02. The business had revenue of $621.20 million during the quarter, compared to analyst estimates of $614.57 million. Clarivate had a positive return on equity of 10.11% and a negative net margin of 39.29%. Sell-side analysts predict that Clarivate will post 0.62 EPS for the current fiscal year.

About Clarivate

(Get Free Report

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.

See Also

Analyst Recommendations for Clarivate (NYSE:CLVT)

Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.